[Event Report] Non-partisan Diet Member Briefing “Intractable and Rare Diseases and AI Diagnostic Support Tools” (July 3, 2026)
date : 7/29/2026
Tags: Diet Member Briefing, Intractable & Rare Diseases, Other Activities
Health and Global Policy Institute (HGPI) hosted an installment of Non-partisan Diet Member Briefing, which is held on an irregular basis to brief non-partisan Diet members on key health policy issues. The concept of this installment was “Considering the Future of Health and Medical Policy with Industry, Government, Academia, and Civil Society.” Working more closely with the legislature than ever before and with support from our non-partisan promoters, our objective was to deepen learning for non-partisan Diet members using concrete and verifiable data in themes with a high degree of public interest including cancer, preventive medicine, internal and surgical diseases, pediatrics, and perinatal care and, with a future-oriented vision, have an equal exchange of opinions on next steps.
This installment focused on the potential of AI diagnostic support tools to enable early detection and improve diagnostic accuracy, as well as the challenges associated with their implementation in society. As a case example, cardiac amyloidosis was presented, which is a condition that is said to be difficult to distinguish from other heart diseases or age-related symptoms in its early stages. The session opened with data analyzing the current state of diagnosis and treatment. Building on this, the session raised the possibility that introducing AI diagnostic support tools could enable early detection of findings for cardiac amyloidosis that are easily overlooked, encourage appropriate testing and referral to specialist care even in regions where specialists are limited, and thereby help address diagnostic delays and regional disparities.
Regarding AI diagnostic support, HGPI published a discussion paper titled “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” in May 2026, the contents of which were also shared with the Diet members in attendance on the day.
【Program】(Titles omitted)
Introduction of HGPI’s Policy Discussion Points
Lecture: “Intractable and Rare Diseases and AI Diagnostic Support Tools”
Kenichi Tsujita (Professor of Cardiology, Kumamoto University / Representative Director, Integrated ATTR-CM Partnership on AI Cardiac Technology (IMPACT))
Q&A Session
■ Non-partisan Diet Member Promoters (Titles omitted; in alphabetical order)
Members of the House of Representatives
Keishi Abe, Shinichi Isa, Naoyuki Ito, Satoshi Umemura, Hiroaki Tabata, Mitsuko Numazaki, Gaku Hashimoto, Toru Fukuta
Members of the House of Councillors
Kozo Akino, Takahiro Anno, Katsuo Oshima, Akira Koike, Hiroyuki Konishi, Hanako Jimi, Mami Tamura, Toshiharu Furukawa

Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Research Report] AMR Policy Update #8: Fostering AMR-Conscious Youth: The Antibiotic Smart Sweden Certificate Program and its Implications for Early Childhood Education (July 1, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Research Report] Medical Practitioner Interviews on the Current State and Issues for Interdepartmental Collaboration in Clinical Practice for Chronic Kidney Disease (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-24
[Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)



